Perrigo (NYSE:PRGO) Upgraded at Wall Street Zen

Key Points

• Wall Street Zen upgraded Perrigo from “buy” to “strong-buy,” while Weiss Ratings made a smaller upgrade from “sell (D-)” to “sell (D).” Overall, analysts maintain an average “Hold” rating with a $19.33 price target.
• Perrigo shares opened at $13.59, above their 50-day and 200-day moving averages, but remain within a broad 12-month range of $9.23 to $22.65. Institutional investors and hedge funds own 95.91% of the stock.
• The company reported quarterly EPS of $0.50, beating estimates of $0.39, on revenue of $1.02 billion; however, revenue declined 3.1% year over year and Perrigo posted a negative net margin of 41.85%.

Perrigo (NYSE:PRGO - Get Free Report) was upgraded by Wall Street Zen from a "buy" rating to a "strong-buy" rating in a research note issued on Saturday, Wall Street Zen reports.

Separately, Weiss Ratings upgraded shares of Perrigo from a "sell (d-)" rating to a "sell (d)" rating in a report on Thursday, August 6th. One analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $19.33.

Perrigo Stock Performance

Shares of NYSE PRGO opened at $13.59 on Friday. The company has a current ratio of 2.32, a quick ratio of 1.32 and a debt-to-equity ratio of 1.31. The stock has a 50 day simple moving average of $12.62 and a 200-day simple moving average of $11.41. The company has a market cap of $1.89 billion, a PE ratio of -1.09, a P/E/G ratio of 1.54 and a beta of 0.59. Perrigo has a 12-month low of $9.23 and a 12-month high of $22.65.

Perrigo (NYSE:PRGO - Get Free Report) last posted its earnings results on Wednesday, August 5th. The company reported $0.50 EPS for the quarter, beating the consensus estimate of $0.39 by $0.11. Perrigo had a positive return on equity of 11.25% and a negative net margin of 41.85%.The firm had revenue of $1.02 billion for the quarter, compared to analysts' expectations of $1.02 billion. During the same period last year, the firm earned ($0.06) EPS. The firm's revenue was down 3.1% compared to the same quarter last year. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. On average, equities research analysts forecast that Perrigo will post 2.18 EPS for the current year.

Institutional Trading of Perrigo

Several large investors have recently added to or reduced their stakes in PRGO. Sequoia Financial Advisors LLC acquired a new position in shares of Perrigo in the 2nd quarter valued at about $207,000. WINTON GROUP Ltd grew its position in Perrigo by 52.9% during the second quarter. WINTON GROUP Ltd now owns 75,700 shares of the company's stock valued at $787,000 after purchasing an additional 26,200 shares in the last quarter. Engineers Gate Manager LP increased its stake in Perrigo by 28.4% in the 2nd quarter. Engineers Gate Manager LP now owns 151,869 shares of the company's stock valued at $1,578,000 after buying an additional 33,554 shares during the period. Integrated Wealth Concepts LLC acquired a new position in Perrigo in the 2nd quarter valued at approximately $126,000. Finally, Allworth Financial LP lifted its position in Perrigo by 489.1% in the 2nd quarter. Allworth Financial LP now owns 9,390 shares of the company's stock worth $98,000 after buying an additional 7,796 shares in the last quarter. 95.91% of the stock is owned by institutional investors and hedge funds.

About Perrigo

Perrigo Company plc is a global consumer self-care company that develops, manufactures and markets over-the-counter (OTC) products and other nonprescription health and wellness products. Its portfolio spans consumer health categories including pain relief, allergy and cold remedies, digestive health, skin care, oral care, vitamins and supplements, and women's health.

The company sells products under both its own brands and retailer-owned store brands through pharmacies, supermarkets, mass merchants, e-commerce channels and other outlets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.